Toward precision medicine in inflammatory breast cancer.

Authors:
Viale G; Marra A; Curigliano G; Criscitiello C.

Journal:
Transl Cancer Res

Publication Year: 2019

DOI:
10.21037/tcr.2019.05.04

PMCID:
PMC8798747

PMID:
35117125

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Transl Cancer Res

Detailed journal information not available.

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

2/6

0.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Conﬂicts of Interest: The focused issue “Rare Tumors of the Breast” was commissioned by the editorial office without any funding or sponsorship. G Curigliano received personal fees from Novartis, Pfizer, and Roche for expert presentations and personal fees as a member of the advisory board for Ellipses Pharma, Foundation Medicine, Lilly, Novartis, Pfizer, Roche, Samsung, and Seattle Genetics. The other authors have no conflicts of interest to declare."

Funding Disclosure

Evidence found in paper:

"Funding: None."

Protocol Registration

Open Access

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025